NCT06130384: Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection. |
|
|
| Completed | 4 | 97 | Canada, US | Use of bromfenac 0.09% to reduce intravitreal injection pain, Use of artificial tears to reduce intravitreal injection pain | Wills Eye | Pain, Intravitreal Injection, Pain, Acute | 08/23 | 11/23 | | |
NCT06229665: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) |
|
|
| Active, not recruiting | 2/3 | 75 | US | Valeda Light Delivery System | LumiThera, Inc., National Eye Institute (NEI) | Dry Age-related Macular Degeneration | 05/25 | 06/25 | | |